TABLE 1.
Cost Item | Inputs | Source/Notes |
---|---|---|
Pretreatment period: lymphodepleting therapy | ||
Regimen 1 | Proportion of patientsa: 94.94% | ELIANA trial10,13 |
Fludarabine | Drug cost: $281.23 Administration cost: $572.32 |
RED BOOK17 CMS Physician Fee Schedule18 |
Cyclophosphamide | Drug cost: $817.47 Administration cost: $138.40 |
RED BOOK17 CMS Physician Fee Schedule18 |
Regimen 2 | Proportion of patientsa: 1.27% | ELIANA trial10,13 |
Cytarabine | Drug cost: $11.40 Administration cost: $138.40 |
RED BOOK17 CMS Physician Fee Schedule18 |
Etoposide | Drug cost: $42.40 Administration cost: $522.21 |
RED BOOK17 CMS Physician Fee Schedule18 |
Infusion period: tisagenlecleucel infusion | ||
Tisagenlecleucel | Drug cost: $475,000 Administration cost: $143.08 |
RED BOOK17 CMS Physician Fee Schedule18 |
a The proportion of patients was estimated based on the observation from the ELIANA trial.
CMS = Centers for Medicare & Medicaid Services.